Check Before You Invest : Colinz Laboratories Ltd

Snapshot

Q.1 Which industry/sub-sector does Colinz Laboratories Ltd belong to?

Colinz Laboratories Ltd belongs to the Healthcare sector, operating specifically within the Pharmaceuticals & Drugs segment.

Q.2 Is Colinz Laboratories Ltd a good quality company?

Colinz Laboratories Ltd is a quality company, based on a 10-year financial track record.

Q.3 Is Colinz Laboratories Ltd undervalued or overvalued?

Colinz Laboratories Ltd appears Overvalued, as its key valuation ratios are above with their past averages.

Q.4 Is Colinz Laboratories Ltd a good buy now?

Colinz Laboratories Ltd is not a good buy now, based on weak price trend analysis suggesting prices may fall. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of Colinz Laboratories Ltd?

Colinz Laboratories Ltd revenue growth is -7.1% for FY-2025, which is below its 5-year CAGR of -2.84%, indicating slower growth.

Q.2 Return on capital employed (ROCE) of Colinz Laboratories Ltd?

Colinz Laboratories Ltd Return on capital employed is 6.74% for FY-2025, which is in line with its 5-year historical median of 6.76%. The current ROCE is below its estimated weighted average cost of capital (WACC) of 14%, indicating value preservation.

Q.3 Return on Asset of Colinz Laboratories Ltd?

Colinz Laboratories Ltd Return on Asset is 4.29%, which is in line with its 5-year historical median of 4.29%, indicating stable asset utilization efficiency.

Q.4 Return on Equity (ROE) of Colinz Laboratories Ltd?

Colinz Laboratories Ltd Return on equity is 5.39% for FY-2025, which is in line with its 5-year historical median of 5.39%, indicating the business is making similar use of its shareholders capital.

Q.5 Cash conversion cycle of Colinz Laboratories Ltd?

Colinz Laboratories Ltd Cash conversion cycle is 50 days, below its 5-year historical median of 73 days, indicating improved working capital management. However, you need to compare this with its peers in the industry.

	Current Level	5-year Historic Median
Asset Turnover	0.56	0.65
ROE	5.39	5.39
ROCE	6.74	6.76
Cash Conversion Cycle	50 days	73 days

Q.6 Gross Profit margin of Colinz Laboratories Ltd?

Colinz Laboratories Ltd Gross profit margin which is the profit after deduction of direct costs, is 11.5% for FY-2025, which is above its 5-year median of 10.2%, indicating increasing margins.

Q.7 Operating Profit Margin of Colinz Laboratories Ltd?

Colinz Laboratories Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is 7.62% for FY-2025, which is in line with its 5-year median of 7.72% indicating stable margins.

Q.8 Net Profit Margin of Colinz Laboratories Ltd?

Colinz Laboratories Ltd Net Profit Margin is 7.61% for FY-2025, is above with its 5-year median of 6.39%, indicating increasing margins.

	Current Level	5-year Historic Median
Gross Profit Margin	11.5	10.2
Operating Profit Margin	7.62	7.72
Net Profit Margin	7.61	6.39

Q.9 Debt to Equity ratio of Colinz Laboratories Ltd?

Colinz Laboratories Ltd Debt-to-Equity ratio is 0.07, which is lower with the industry average of 0.27, indicating lower debt levels in the industry.

Q.10 Debt to cash flow from operations of Colinz Laboratories Ltd?

Colinz Laboratories Ltd Debt to cash flow from operations is -0.44, which is at a unhealthy level.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Colinz Laboratories Ltd?

Promoters hold 66.00% of the Colinz Laboratories Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Colinz Laboratories Ltd vs industry peers?

Colinz Laboratories Ltd revenue CAGR is -2.84%, compared to the industry median CAGR of 8.30%, indicating slower growth and losing its market share.

Profit Metrics

	Current Level	5-year Industry Median
Revenue Growth	-7.1	8.3
Gross Profit Growth	-3.9	14.7
Operating Profit Growth	-7.4	11.4
Net Profit Growth	2	NAN

Operating Efficiency

	Current Level	5-year Industry Median
Asset Turnover	0.56	0.81
ROE	5.39	9.49
ROCE	6.74	11.91
Cash Conversion Cycle (days)	49.94	85

Valuation & price assessment

Q.1 Stock return of Colinz Laboratories Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of 14.6% based on the current price.

Q.2 What return has the stock given over the last decade?

	9Y	5Y	3Y	1Y
Share Price CAGR	14.6%	28.5%	8.9%	3.7%

Q.3 Valuation ratios of Colinz Laboratories Ltd vs historical?

The current P/E is lower that its historical median.

Q.4 How do the current valuation ratios compare with 5-year historical median and industry numbers?

Valuation Ratios	Current	5-year Historic Median	5-year Industry Median
Price to Earnings	24.55	26.17	31.09
Price to Book	1.25	1.23	2.85
Price to Sales	2.05	1.59	2.79
EV to EBITDA	5	7.72	15.87

Check more companies

5. Wockhardt

8. Pfizer

10. Neuland Laboratories

Check trending companies

1. Jupiter Wagons Ltd.

2. Yes Bank Ltd.

3. RBL Bank Ltd.

4. Samvardhana Motherson International Ltd.

5. Jindal Saw Ltd.